Krystal Biotech Inc (KRYS)

Aug 01, 2025

Local biotech co-founder named to Forbes 50 Over 50 - The Business Journals

Aug 01, 2025

Aug 01, 2025

KRYSTAL BIOTECH Earnings Preview: Recent $KRYS Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative

Aug 01, 2025

Aug 01, 2025

Earnings Outlook For Krystal Biotech - 富途牛牛

Aug 01, 2025

Aug 01, 2025

What makes Krystal Biotech Inc. stock price move sharplyTrend Reversal Signal Prediction Outlook - beatles.ru

Aug 01, 2025

Jul 31, 2025

What are analysts’ price targets for Krystal Biotech Inc. in the next 12 monthsDaily Trading Opportunities For Consistent Profits - jammulinksnews.com

Jul 31, 2025

Jul 31, 2025

How does Krystal Biotech Inc. compare to its industry peersEarnings Report Growth Plan For Smart Trading - jammulinksnews.com

Jul 31, 2025

Jul 31, 2025

Why is Krystal Biotech Inc. stock attracting strong analyst attentionAI Powered Growth Plan From AI Tools - jammulinksnews.com

Jul 31, 2025

Jul 31, 2025

Quantitative breakdown of Krystal Biotech Inc. recent moveAlpha Driven Watchlist With Alerts Published - metal.it

Jul 31, 2025

Jul 30, 2025

How Krystal Biotech Inc. stock performs during market volatilityTechnical Stock Breakout Predictions Signal Entry Points - metal.it

Jul 30, 2025

Jul 29, 2025

Why Krystal Biotech Inc. stock attracts strong analyst attentionWeekly Chart Analysis With Entry Advice Provided - metal.it

Jul 29, 2025

Jul 29, 2025

Why We're Not Concerned About Krystal Biotech, Inc.'s (NASDAQ:KRYS) Share Price - 富途牛牛

Jul 29, 2025

Jul 29, 2025

Krystal Biotech to Report Second Quarter 2025 Financial Results on August 4, 2025 - The Manila Times

Jul 29, 2025

Jul 29, 2025

Will Krystal Biotech Inc. Recover After Recent DeclineIntraday Trend Analysis for Fast Gains Released - metal.it

Jul 29, 2025

Jul 28, 2025

What is the risk reward ratio of investing in Krystal Biotech Inc. stockAdvanced Screener Guidance With High Returns - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

Krystal Biotech receives regulatory approval to expand to Japan - The Business Journals

Jul 28, 2025

Jul 28, 2025

Krystal Biotech, Inc. (KRYS) to Report Q2 Results: Wall Street Expects Earnings Growth - Yahoo Finance

Jul 28, 2025

Jul 28, 2025

Krystal Biotech’s Vyjuvek authorised in Japan to treat DEB - World Pharmaceutical Frontiers

Jul 28, 2025

Jul 28, 2025

What is the dividend policy of Krystal Biotech Inc. stockUnlock your portfolio’s hidden potential - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

How volatile is Krystal Biotech Inc. stock compared to the marketFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

What catalysts could drive Krystal Biotech Inc. stock higher in 2025Post Market Outlook For Smart Trading - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

Is Krystal Biotech Inc. stock overvalued or undervaluedUnlock your portfolio’s full growth potential - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

Krystal Biotech Retains 'Buy' Rating with $219 Price Target - AInvest

Jul 27, 2025

Jul 25, 2025

Krystal Biotech’s Subsidiary Reports Positive Phase 1 Results - The Globe and Mail

Jul 25, 2025

Jul 25, 2025

A Quick Look at Today's Ratings for Krystal Biotech(KRYS.US), With a Forecast Between $192 to $240 - 富途牛牛

Jul 25, 2025

Jul 25, 2025

Krystal Biotech (KRYS) Retains 'Buy' Rating with $219 Price Targ - GuruFocus

Jul 25, 2025

Jul 25, 2025

What analysts say about Krystal Biotech Inc. stockSuperior returns - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Positive Phase 1 Trial Results for KB304 Bolster Buy Rating for Krystal Biotech Amidst Promising Market Potential - TipRanks

Jul 25, 2025

Jul 25, 2025

Krystal Biotech Gains Approval for DEB Treatment in Japan - TipRanks

Jul 25, 2025

Jul 25, 2025

Krystal Biotech Announces Approval of VYJUVEK® by Japan’s Ministry of Health, Labour and Welfare for the Treatment of Dystrophic Epidermolysis Bullosa - The Manila Times

Jul 25, 2025

Jul 25, 2025

Krystal Biotech's VYJUVEK Receives Approval in Japan for Dystrophic Epidermolysis Bullosa Treatment from Birth - Quiver Quantitative

Jul 25, 2025

Jul 25, 2025

Is Krystal Biotech Inc. a good long term investmentFree Predictions - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

What risks could impact Krystal Biotech Inc. stock performanceTremendous gains - jammulinksnews.com

Jul 25, 2025

Jul 24, 2025

Krystal Biotech’s Promising Aesthetic Developments and Positive Phase I Results Justify Buy Rating - TipRanks

Jul 24, 2025

Jul 24, 2025

What drives Krystal Biotech Inc. stock priceFree Wealth Management Insights - PrintWeekIndia

Jul 24, 2025

Jul 24, 2025

Jeune Announces Positive Results and Significant Aesthetic - GlobeNewswire

Jul 24, 2025

Jul 24, 2025

Analysts Offer Insights on Healthcare Companies: Krystal Biotech (KRYS), Abivax SA Sponsored ADR (ABVX) and Kyowa Kirin Co (OtherKYKOF) - The Globe and Mail

Jul 24, 2025

Jul 24, 2025

Phase 1 Trial Shows 100% Success Rate for Novel Décolleté Wrinkle Treatment | KRYS Stock News - Stock Titan

Jul 24, 2025

Jul 23, 2025

Krystal Biotech Inc. Stock Analysis and ForecastFree Stock Movement Tracking - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

Krystal Biotech (KRYS) Gets a Buy from Bank of America Securities - The Globe and Mail

Jul 23, 2025